LU51221A1 - - Google Patents

Info

Publication number
LU51221A1
LU51221A1 LU51221A LU51221A LU51221A1 LU 51221 A1 LU51221 A1 LU 51221A1 LU 51221 A LU51221 A LU 51221A LU 51221 A LU51221 A LU 51221A LU 51221 A1 LU51221 A1 LU 51221A1
Authority
LU
Luxembourg
Application number
LU51221A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU51221A1 publication Critical patent/LU51221A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU51221A 1965-06-02 1966-05-31 LU51221A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46082965A 1965-06-02 1965-06-02

Publications (1)

Publication Number Publication Date
LU51221A1 true LU51221A1 (xx) 1966-08-01

Family

ID=23830233

Family Applications (1)

Application Number Title Priority Date Filing Date
LU51221A LU51221A1 (xx) 1965-06-02 1966-05-31

Country Status (6)

Country Link
US (1) US3549766A (xx)
BE (1) BE681890A (xx)
DE (1) DE1617375A1 (xx)
DK (1) DK119219B (xx)
GB (1) GB1094083A (xx)
LU (1) LU51221A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007353A1 (en) * 1985-06-14 1986-12-18 Pfizer Inc. Intermediate in the production of an asymmetric hydantoin
US4822610A (en) * 1986-11-07 1989-04-18 Bush Irving M Method for the treatment of urologic disorders
EP0424553A1 (en) * 1989-10-23 1991-05-02 Frank M. Berger Substituted phenoxy alkanols for treatment of contact hypersensitivity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759577A (en) * 1953-12-17 1956-10-17 Bristol Lab Inc Oral therapeutic preparations containing coconut oil

Also Published As

Publication number Publication date
DK119219B (da) 1970-11-30
GB1094083A (en) 1967-12-06
US3549766A (en) 1970-12-22
BE681890A (xx) 1966-10-31
DE1617375A1 (de) 1970-06-25

Similar Documents

Publication Publication Date Title
BE681890A (xx)
BE658577A (xx)
BE659089A (xx)
BE661289A (xx)
BE663056A (xx)
BE663744A (xx)
BE664290A (xx)
BE664333A (xx)
BE666221A (xx)
BE666893A (xx)
BE668297A (xx)
BE669021A (xx)
BE669209A (xx)
BE669498A (xx)
BE669527A (xx)
BE670193A (xx)
BE671639A (xx)
BE671734A (xx)
BE671747A (xx)
BE672745A (xx)
BE673907A (xx)
BE673917A (xx)
BE674057A (xx)
BE674137A (xx)
BE674412A (xx)